(Q51322645)

English

Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes.

scientific article published on 19 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

Giuseppe Derosa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Aldo Bonaventura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

L Bianchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

D Romano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

E Fogari

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

A D'Angelo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

P Maffioli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

19 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1515-1523

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Dipeptidyl peptidase-4 inhibitors: 3 years of experience.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Adipocytokine levels in obese and non-obese subjects: an observational study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Candesartan effect on inflammation in hypertension

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Postprandial lipoproteins and progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FDME.12499

21 January 2018

Identifiers

10.1111/DME.12499

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24824633%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51322645&oldid=1940124077"